ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements
Salem Erode Investments extended its rights issue closing date by six days to October 1. Revised allotment and listing dates shift to October 5 and 7 respectively.
Promoter ICL Fincorp renounced its rights entitlement in favour of 22 specific investors. They applied for up to 54,00,000 shares under the Rights Issue.
Salem Erode Investments Ltd. has scheduled its 95th Annual General Meeting for September 30, 2026, to be conducted via video conferencing.
Salem Erode Investments re-appointed Mr. Ambadath Aiyyappan Balan as an Independent Director for a five-year term. The board also convened its 95th Annual General Meeting for September 30, 2026.
Salem Erode Investments Ltd has fixed September 03, 2026, as the record date for its upcoming Rights Issue. The company has also announced the ISIN for rights entitlements.
Salem Erode Investments Ltd approved a rights issue of up to 1.15 crore shares at ₹20 per share, raising approximately ₹22.93 Crore.
Salem Erode Investments Limited approved a rights issue of 1.15 crore equity shares at ₹20 each, aggregating to ₹22.93 crore. The record date is September 3, 2026.
Salem Erode Investments will hold a board meeting on August 29, 2026, to determine the terms and conditions of its proposed rights issue.
Salem Erode Investments Ltd reported revenue from operations of ₹0.9 Cr (-18.2% YoY) and a net loss of ₹1.3 Cr for Q1 FY27.
Salem Erode Investments Ltd has scheduled a board meeting for August 13, 2026, to consider and approve the financial results for the quarter ended June 30, 2026.
Salem Erode Investments allotted 36,950 unlisted secured redeemable non-convertible debentures for ₹3.695 Crore on a private placement basis.
Salem Erode Investments Ltd board approved the issue of 40,000 unlisted non-convertible debentures on a private placement basis, aggregating to ₹4 Crore.
Salem Erode Investments Ltd has scheduled a Board Meeting for July 23, 2026, to consider raising funds through the issuance of Secured Redeemable Non-Convertible Debentures.
Salem Erode Investments approved the allotment of NCDs worth ₹0.92 Crore. These secured redeemable debentures were issued via private placement.
Salem Erode Investments Ltd reported revenue from operations of ₹0.7 Cr (-22.2% YoY) and a net loss of ₹1.4 Cr for Q4 FY26.
Salem Erode Investments reported its audited FY2026 financial results and re-appointed its internal and secretarial auditors. The board approved these outcomes during its May 2026 meeting.
Salem Erode Investments scheduled a board meeting for May 26, 2026. Directors will consider and approve audited standalone financial results for the 2026 fiscal year.
Salem Erode Investments Ltd confirmed it does not fall under the 'Large Corporate' category per SEBI framework as of March 31, 2026. The company reported outstanding borrowings of ₹13.12 Crore and a BB credit rating from CRISIL. Consequently, mandatory incremental borrowing requirements for large corporates do not apply.
Salem Erode Investments Ltd clarified that recent share price movement may be linked to its Board's approval of a ₹22.93 Crore rights issue on March 24, 2026. The company confirmed compliance with insider trading regulations and stated no other undisclosed material information exists.